Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
- Status
- COMPLETED
- Phase
- PHASE4
Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE4
Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
- Status
- COMPLETED
- Phase
- PHASE2
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Ruxolitinib Versus Best Available Therapy Trial in Patients With High Risk ET in Second Line
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery
- Status
- COMPLETED
- Phase
- PHASE2
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1